文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

伊朗的皮肤利什曼病:系统评价和荟萃分析。

Cutaneous leishmaniasis in Iran: A systematic review and meta-analysis.

机构信息

Vector-borne Disease Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Infectious and Tropical Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

出版信息

Microb Pathog. 2021 Mar;152:104721. doi: 10.1016/j.micpath.2020.104721. Epub 2021 Feb 1.


DOI:10.1016/j.micpath.2020.104721
PMID:33539962
Abstract

Cutaneous leishmaniasis as a public health concern that attracts many attentions in endemic area. There is no exact estimation of cutaneous leishmaniasis in Iran. This study aimed to assess the exact prevalence of disease and carried out in databases including: Pub Med, Google Scholar, Science Direct, Scopus, Web of Science, Magiran, Iran doc, Barakatkns and Scientific Information Database (SID) from 2000 to 2019. Totally 84 studies were eligible to be included in this systematic review and Meta-analysis study. Based on a random effect model the pooled prevalence of leishmaniasis was estimated 45% (95% CI: 39%-51%; I^2 = 99.8%P < 0.001). The highest prevalence of CL was related to Isfahan 66% (53%-78%), Golestan 64% (62%-65%) and Fars province 63% (38%-84%) and the lowest prevalence was estimated in Kermanshah province 4% (4%-5%), Hormozgan 10% (8%-11%), Bushehr 12% (1%-35%) and Kerman 15% (9%-22%) provinces respectively. The lowest prevalence was associated with L. trapica spices 23% (11%-38%) and the highest was associated with L. major spices 32% (21%-45%). The prevalence with both L. trapica and L. major spices was achieved 60% (48%-71%). It is essential for health authorities to take steps to control and prevent the epidemic by rapid treatment of patients, destroying gerbils and promotion of general and health education for the local population.

摘要

皮肤利什曼病作为一个公共卫生关注点,在流行地区引起了广泛关注。伊朗对皮肤利什曼病的准确估计尚不清楚。本研究旨在评估疾病的确切流行率,并在包括以下数据库的研究中进行:Pub Med、Google Scholar、Science Direct、Scopus、Web of Science、Magiran、Iran doc、Barakatkns 和 Scientific Information Database (SID) 中进行了检索,检索时间范围为 2000 年至 2019 年。共有 84 项研究符合本系统评价和 Meta 分析研究的纳入标准。基于随机效应模型,估计利什曼病的总患病率为 45%(95%CI:39%-51%;I^2=99.8%,P<0.001)。CL 的最高患病率与伊斯法罕有关,为 66%(53%-78%),戈勒斯坦为 64%(62%-65%),法尔斯省为 63%(38%-84%),而最低患病率估计在克尔曼省为 4%(4%-5%),霍尔木兹甘省为 10%(8%-11%),布什尔省为 12%(1%-35%),克尔曼省为 15%(9%-22%)。与 L. trapica 相关的最低患病率为 23%(11%-38%),与 L. major 相关的最高患病率为 32%(21%-45%)。同时与 L. trapica 和 L. major 相关的患病率为 60%(48%-71%)。卫生当局必须采取措施,通过迅速治疗患者、消灭沙鼠和向当地居民推广一般和健康教育来控制和预防该疾病的流行。

相似文献

[1]
Cutaneous leishmaniasis in Iran: A systematic review and meta-analysis.

Microb Pathog. 2021-3

[2]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[3]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[4]
Home treatment for mental health problems: a systematic review.

Health Technol Assess. 2001

[5]
Burden and risk factors of cutaneous leishmaniasis in Ethiopia: a systematic review and meta-analysis.

Int J Dermatol. 2022-11

[6]
Eliciting adverse effects data from participants in clinical trials.

Cochrane Database Syst Rev. 2018-1-16

[7]
Seroprevalence of bovine viral diarrhea virus (BVDV) infection in cattle population in Iran: a systematic review and meta-analysis.

Trop Anim Health Prod. 2021-9-17

[8]
Selegiline for Alzheimer's disease.

Cochrane Database Syst Rev. 2003

[9]
Psychological and/or educational interventions for the prevention of depression in children and adolescents.

Cochrane Database Syst Rev. 2004

[10]
Heated tobacco products for smoking cessation and reducing smoking prevalence.

Cochrane Database Syst Rev. 2022-1-6

引用本文的文献

[1]
Therapeutic Effect of Barberry (Berberis vulgaris) Root Extract on Experimental Cutaneous Leishmaniosis in a BALB/c Mouse Model.

Vet Med Sci. 2025-9

[2]
Phylogenetic insights into Leishmania species circulating among humans, vectors, and reservoir hosts in Shiraz, Southern Iran: implications for leishmaniasis control.

Sci Rep. 2025-5-27

[3]
Mutual Role of Patients and the Healthcare System in the Control of Cutaneous Leishmaniasis.

Transbound Emerg Dis. 2023-8-26

[4]
Comparative Analysis of Microscopy, Leishmanin Skin Test (LST), and Direct Agglutination Test (DAT) for the Diagnosis of Human Cutaneous Leishmaniasis.

Iran J Parasitol. 2025

[5]
Epidemiology and future risk estimates of cutaneous leishmaniasis in district Dera Ismail Khan, Pakistan: analysis of data from 2019-2022.

Afr Health Sci. 2024-12

[6]
qPCR as a Tool for the Diagnosis of Visceral and Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis.

Acta Parasitol. 2025-1-7

[7]
A novel inhibitory strategy of using and killer toxins.

Future Microbiol. 2025-2

[8]
Molecular detection of DNA in wild-caught sand flies, and spp. in northern Iran.

Parasite Epidemiol Control. 2024-11-26

[9]
Spatial and temporal modeling of the global burden of Cutaneous Leishmaniasis in Brazil: A 21-year ecological study.

PLoS Negl Trop Dis. 2024-11

[10]
Canine leishmaniasis caused by Leishmania Tropica in southeastern Iran: a case series study.

Sci Rep. 2024-10-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索